UPDATE : Thursday, September 12, 2019
Local hospitals develop humanized antibody to treat lupus nephritis
A joint research team of local hospitals has developed a humanized antibody...
by Lee Han-soo  |  2019-09-04 15:15
Biohealth R&D budget up 16% next year
The government said it would make a public-private joint system to innovate...
by Kwak Sung-sun  |  2019-09-04 15:14
'Surgical effect of constrictive pericarditis predictable'
Researchers at Samsung Medical Center have published a new indicator that c...
by Lee Han-soo  |  2019-09-03 16:04
Takeda Korea vows to release 16 new drugs by 2023
Takeda Pharmaceutical Korea on Tuesday held the first news conference after...
by Kim Yun-mi  |  2019-09-03 15:40
Health insurance agency invites officials from African countries
The National Health Insurance Service (NHIS) and the Korea Foundation for I...
by Lee Han-soo  |  2019-09-03 15:09
SK goes global by developing new drugs, conducting CDMO biz
SK Holdings is integrating three pharmaceutical production subsidiaries aro...
by Jeong Sae-im  |  2019-09-03 14:58
Multiple myeloma treatment isatuximab named orphan drug
The drug regulator designated isatuximab, a treatment for relapsed and refr...
by Lee Hye-seon  |  2019-09-03 11:21
Hanmi, Daewoong among 20 innovative top-tier drugmakers in Asia Pacific
Hanmi Pharmaceutical and Daewoong Pharmaceutical were included in the top 2...
by Jeong Sae-im  |  2019-09-02 17:33
Real-world data of Saxenda disclosed for 1st time in Asia
Korean researchers have disclosed Asia’s first real-world data of Saxenda, ...
by Kim Yun-mi  |  2019-09-02 14:39
Antidiabetic Forxiga proves efficacy in heart failure
AstraZeneca said it has confirmed that its diabetes drug Forxiga (ingredien...
by Kim Yun-mi  |  2019-09-02 11:35
Daewoong, Medytox differ in interpreting spore appraisal for Nabota
Daewoong Pharmaceutical said Friday that it has gained the upper hand in th...
by Lee Han-soo  |  2019-08-30 16:26
Atopic dermatitis patients fall in despair as Dupixent may not get coverage soon
Sanofi’s new biologic agent Dupixent (ingredient: dupilumab) for severe ato...
by Kim Yun-mi  |  2019-08-30 16:26
Doctors seem less eager to participate in ‘No-Japan’ campaign. Why?
The boycott of Japanese products has been intensifying over the past few mo...
by Lee Han-soo  |  2019-08-30 15:58
JW Pharmaceutical’s hyperlipidemia drug Livalo safe from diabetes risk
JW Pharmaceutical said more countries have recognized that its cholesterol-...
by Jeong Sae-im  |  2019-08-30 14:49
Change in licensing-out contract may be bad sign for Intron Biotechnology
Intron Biotechnology said the conditions for last November’s deal with a mu...
by Jeong Sae-im  |  2019-08-30 14:47
'Mucosa healing essential for treating inflammatory bowel disease'
Takeda's Kynteles (Ingredient: Vedolizumab) is attempting a paradigm sh...
by Lee Han-soo  |  2019-08-30 12:42
University researchers develop vaccine for severe fever with SFTS infection
A research team composed of two local universities -- Korea Advanced Instit...
by Lee Han-soo  |  2019-08-29 17:46
SNUDH to commercialize world's 1st treatment for teeth sensitive to cold
A local hospital’s research team has developed the world's first method...
by Lee Han-soo  |  2019-08-29 15:34
‘Vaping reduces harm from tobacco’
The health authorities need a smoking cessation policy that promotes the us...
by Park Gi-taek  |  2019-08-29 15:33
CAR-T therapy Kymriah, pie in the sky for Korean patients
Kymriah, Novartis’ new CAR-T (chimeric antigen receptor T-cell) treatment, ...
by Kim Yun-mi  |  2019-08-29 14:35
Back to Top